Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Remedy Q4’25: The stakes are high

Remedy Entertainment

Remedy's investment story is entering a pivotal year, as the company is about to release what is arguably its most important game so far: Control Resonant. For the value creation of Remedy's share, it is essential to succeed with the release. Analyst Atte Riikola summarizes.

Stay up to date
Analyst Interviews

Recent videos

HCA Morgenbørs 10/04 - Flade markeder og usikkerhed
10.04.2026, 09.42 Novo Nordisk
BioPorto: Frasalg af antistofforretningen, konsekvenser for planer og kapital
09.04.2026, 15.57 BioPorto
Lundbeck - Introduktion til aktien
09.04.2026, 13.00 Lundbeck
Duell, Webcast, Q2'26
09.04.2026, 09.30 Duell
HCA Morgenbørs 09/04 - Marked tager sig en pause ovenpå gårsdagens relief rally
09.04.2026, 09.23 Torm
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.